ÂÜÀòÂÒÂ×

Bill has over 20 years of financial expertise, including extensive experience raising capital for growth organizations. Prior to joining Karius, he helped build the finance team at Freenome, an innovative liquid biopsy company. Before moving into the diagnostics industry, Bill was an award-winning equity analyst at RBC Capital Markets and Piper Sandler, leading its healthcare research team. He also helped raise nearly $8B in growth capital for top Diagnostics and Life Science Tools companies during his tenure on Wall Street. Bill completed his MBA at the University of Minnesota’s Carlson School of Management and holds the CFA designation.